Significant improvement of results Very strong revenue growth: +36%Another surge in sales of LISA TRACKER® kits: +150%Stable operating costs3-point increase in the gross marginCroissy-Beaubourg and Montpellier, September 14, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER),…
Croissy-Beaubourg and Montpellier, September 14, 2016 – Theradiag (ISIN: FR0004197747, Ticker: ALTER, eligible for PEA-PME plans), a company specializing in in vitro diagnostics and theranostics, is today announcing that it carried out a capital increase fully…
Croissy-Beaubourg and Montpellier, September 5, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specialized in in vitro diagnostics and theranostics, reports that, on August 29, Janssen Biotech Inc. announced the launch of a…